MELAS-like encephalomyopathy caused by a new pathogenic mutation in the mitochondrial DNA encoded cytochrome c...

Area of Science:

• Mitochondrial Medicine
• Neurogenetics
• Molecular Biology

Background:

• Mitochondrial disorders can present with diverse neurological and muscular symptoms.
• Cytochrome c oxidase (COX) deficiency, a common mitochondrial defect, affects cellular energy production.
• Identifying novel mutations is crucial for understanding disease mechanisms.

Observation:

• A 35-year-old woman experienced stroke-like episodes, seizures, hearing loss, migraine, and progressive myopathy.
• Neurological examination revealed a T2-hyperintense lesion, while muscle biopsy showed ragged-red fibers and COX deficiency.
• She also presented with short stature and secondary hypogonadism but had successful pregnancies.

Findings:

• A novel heteroplasmic mitochondrial DNA mutation, m.6597C>A in the MTCOI gene, was identified.
• This mutation leads to a p.Q232K amino acid change in cytochrome c oxidase subunit I.
• Functional studies confirmed the mutation causes isolated COX deficiency.

Implications:

• This discovery expands the mutational spectrum of mitochondrial COX deficiency.
• It highlights the importance of mitochondrial DNA analysis in patients with complex neurological and muscular phenotypes.
• Understanding this mutation aids in diagnosing and potentially managing similar mitochondrial diseases.